4.7 Letter

Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Virology

Pityriasis rosea and COVID-19

Stefano Veraldi et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Letter Dermatology

Pityriasis rosea as a leading manifestation of COVID-19 infection

R. Merhy et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

A. H. Ehsani et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Letter Dermatology

Cutaneous manifestations in COVID-19: a first perspective

S. Recalcati

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Article Dermatology

Pityriasis Rosea: A Comprehensive Classification

Francesco Drago et al.

DERMATOLOGY (2016)

Letter Dermatology

The efficacy of macrolides and acyclovir in pityriasis rosea

Francesco Drago et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2015)